Expanding Options in Data Analysis

Microarray technology allows the simultaneous monitoring of expression levels of thousands of genes and even whole genomes. But the experiments themselves represent only the opening act. The grand finale, so to speak, is the data analysis. Sophisticated statistical software and tools exist, but the sheer volume of data, the likes of which are unfamiliar to most biologists (and most statisticians), still represents the primary hurdle in DNA microarray research."Five years ago, there were no stati

Written byEmma Hitt
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Microarray technology allows the simultaneous monitoring of expression levels of thousands of genes and even whole genomes. But the experiments themselves represent only the opening act. The grand finale, so to speak, is the data analysis. Sophisticated statistical software and tools exist, but the sheer volume of data, the likes of which are unfamiliar to most biologists (and most statisticians), still represents the primary hurdle in DNA microarray research.

"Five years ago, there were no statisticians in the field, and molecular biologists were not talking to statisticians," says Thomas J. Downey, president and CEO of Partek, a St. Charles, Mo.-based provider of statistical and visual pattern-recognition software for scientists. "I was saying, 'Hey, we need to be using statistics on this data,' and they would throw me out of the room." But things are different now, he says: "More statisticians have entered the field, although I think there is plenty ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies